Development of NTX-472, a Formulated Mrna Therapy Targeting CD20, CD19, and CD47, for Treatment of B-cell Lymphoma.
Journal of Clinical Oncology(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined